Literature DB >> 16428124

Metabolic syndrome throughout the menopausal transition: influence of age and menopausal status.

V R Mesch1, L E Boero, N O Siseles, M Royer, M Prada, F Sayegh, L Schreier, H J Benencia, G A Berg.   

Abstract

OBJECTIVE: To assess the relationship between the main components of both the metabolic syndrome and insulin resistance and menopausal status in the menopausal transition.
METHODS: A total of 124 healthy women were divided into four groups according to their menstrual status: the first group consisted of 35 women in menopausal transition with menstrual bleeding (MTM) and with cycles between 35 and 80 days; the second group was composed of 29 women in menopausal transition with 3-6 months of amenorrhea (MTA). The third group consisted of 31 postmenopausal women (PostM) and the fourth group of 29 premenopausal women (PreM) with regular cycles. The metabolic syndrome was evaluated following the ATP III criteria. Evaluation of insulin resistance was made through the HOMA, QUICKI and McAuley indices and the triglycerides/high density lipoprotein (HDL) cholesterol ratio.
RESULTS: The triglycerides/HDL cholesterol ratio increased in MTM, MTA and PostM women in comparison with PreM women. A slight decrease in the QUIKI index (p = 0.06) and a decrease in the McAuley index (p < 0.001) were observed in MTM, MTA and PostM women in comparison to PreM women. The relative frequencies of metabolic syndrome in the four groups were: PreM, 0%; MTM, 20%; MTA, 21%; and PostM, 22% (p = 0.0001). The most frequent markers of the metabolic syndrome were increased waist circumference, low HDL cholesterol levels and hypertension. Linear regression between menopausal status and metabolic syndrome was lost when age was added to the model.
CONCLUSIONS: The frequency of metabolic syndrome increased from the time of the menopausal transition to the postmenopause. Abdominal obesity was the most frequent feature observed. Nevertheless, aging erased the effect of the menopause on the metabolic syndrome. In order to prevent cardiovascular disease, the metabolic syndrome must be evaluated from the time of the menopausal transition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16428124     DOI: 10.1080/13697130500487331

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  21 in total

1.  Physical training improves visceral adipose tissue health by remodelling extracellular matrix in rats with estrogen absence: a gene expression analysis.

Authors:  Fernanda O Duarte; Camila do Valle Gomes-Gatto; Jorge C Oishi; Anderson Diogo de S Lino; Uliana S Stotzer; Maria Fernanda C Rodrigues; Guilherme H Gatti da Silva; Heloisa S Selistre-de-Araújo
Journal:  Int J Exp Pathol       Date:  2017-09-08       Impact factor: 1.925

Review 2.  Drospirenone, a new progestogen, for postmenopausal women with hypertension.

Authors:  Madhavi Mallareddy; Vladimir Hanes; William B White
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

3.  Dose effect of cardiorespiratory exercise on metabolic syndrome in postmenopausal women.

Authors:  Conrad P Earnest; Neil M Johannsen; Damon L Swift; Carl J Lavie; Steven N Blair; Timothy S Church
Journal:  Am J Cardiol       Date:  2013-04-08       Impact factor: 2.778

4.  Adipocytokine and ghrelin levels in relation to cardiovascular disease risk factors in women at midlife: longitudinal associations.

Authors:  R P Wildman; P Mancuso; C Wang; M Kim; P E Scherer; M R Sowers
Journal:  Int J Obes (Lond)       Date:  2008-01-08       Impact factor: 5.095

5.  Cardiorespiratory Fitness and Metabolic Syndrome in Postmenopausal African-American Women.

Authors:  L L Adams-Campbell; C Dash; B H Kim; J Hicks; K Makambi; J Hagberg
Journal:  Int J Sports Med       Date:  2016-02-02       Impact factor: 3.118

6.  The Relationship Between Menopause and Metabolic Syndrome: Experimental and Bioinformatics Analysis.

Authors:  Abir Jaballah; Ismael Soltani; Wael Bahia; Azza Dandana; Yosra Hasni; Abdelhedi Miled; Salima Ferchichi
Journal:  Biochem Genet       Date:  2021-05-10       Impact factor: 1.890

7.  Menopause and metabolic syndrome: A study of 498 urban women from western India.

Authors:  Shefali Pandey; Manisha Srinivas; Shubhada Agashe; Jayashree Joshi; Priti Galvankar; C P Prakasam; Rama Vaidya
Journal:  J Midlife Health       Date:  2010-07

8.  The InterLACE study: Design, data harmonization and characteristics across 20 studies on women's health.

Authors:  Gita D Mishra; Hsin-Fang Chung; Nirmala Pandeya; Annette J Dobson; Lee Jones; Nancy E Avis; Sybil L Crawford; Ellen B Gold; Daniel Brown; Lynette L Sievert; Eric Brunner; Janet E Cade; Victoria J Burley; Darren C Greenwood; Graham G Giles; Fiona Bruinsma; Alissa Goodman; Kunihiko Hayashi; Jung Su Lee; Hideki Mizunuma; Diana Kuh; Rachel Cooper; Rebecca Hardy; Carla Makhlouf Obermeyer; Kathryn A Lee; Mette Kildevæld Simonsen; Toyoko Yoshizawa; Nancy F Woods; Ellen S Mitchell; Mark Hamer; Panayotes Demakakos; Sven Sandin; Hans-Olov Adami; Elisabete Weiderpass; Debra Anderson
Journal:  Maturitas       Date:  2016-08-04       Impact factor: 4.342

9.  Metabolic syndrome among pre- and post-menopausal rural women in Bangladesh: result from a population-based study.

Authors:  Subrina Jesmin; A M Shahidul Islam; Shamima Akter; Md Majedul Islam; Sayeeda Nusrat Sultana; Naoto Yamaguchi; Osamu Okazaki; Masao Moroi; Michiaki Hiroe; Sosuke Kimura; Tetsu Watanabe; Kawano Saturo; Taro Mizutani
Journal:  BMC Res Notes       Date:  2013-04-18

10.  Metabolic syndrome and menopause.

Authors:  Zahra Jouyandeh; Farnaz Nayebzadeh; Mostafa Qorbani; Mojgan Asadi
Journal:  J Diabetes Metab Disord       Date:  2013-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.